HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required) | RFA AI 19 001

Opportunity Information: Apply for RFA AI 19 001

The HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required) funding opportunity (RFA-AI-19-001) is a National Institutes of Health cooperative agreement announcement aimed at supporting dedicated Laboratory Centers (LCs) that serve the HIV/AIDS Clinical Trials Networks supported by NIAID. The central goal is to fund laboratories that can provide the leadership, organizational structure, and operational capabilities needed to design, support, and carry out the laboratory portions of the Networks research agendas. In practice, this means the award is intended to underwrite a lab-centered framework that helps clinical trials and related network studies run smoothly from a laboratory standpoint, including the planning, coordination, and execution of lab-based components that are essential to HIV/AIDS clinical research.

This opportunity uses the UM1 mechanism, which signals a cooperative agreement rather than a standard grant. With a cooperative agreement, NIH typically expects substantial involvement from the agency during the project period, often including coordinated decision-making, shared governance, and ongoing collaboration between awardees and NIH program staff. The title also specifies “Clinical Trial Required,” indicating that the funded activity is expected to be closely tied to clinical trials work and that applicants should be prepared to support laboratory functions that are integral to clinical trial implementation, oversight, and deliverables within the HIV/AIDS Clinical Trials Networks structure.

Eligible applicants are broad and include many types of U.S.-based organizations and governmental entities. These include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education when applying under those nonprofit categories); for-profit organizations other than small businesses; small businesses; and other eligible entities. The announcement explicitly notes additional categories that may apply, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), as well as faith-based or community-based organizations and eligible federal agencies. Regional organizations and U.S. territories or possessions are also mentioned as eligible applicant types.

At the same time, the geographic and organizational eligibility boundaries are clearly defined. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply as the applicant organization. In addition, non-domestic components of U.S. organizations are not eligible to apply. However, the FOA allows “foreign components” as defined in the NIH Grants Policy Statement, meaning a U.S.-based applicant may include certain foreign activities or collaborations as part of the proposed project if they meet NIH policy requirements and are appropriately justified, even though a foreign institution cannot be the primary applicant.

Administrative details provided with the source data include that this is a discretionary funding opportunity under NIH, categorized within education, health, income security, and social services. The CFDA numbers associated with the announcement are 93.121, 93.242, 93.279, 93.853, 93.855, and 93.865. The posting (creation) date is January 24, 2019, and the original closing date listed is August 1, 2019. The agency is the National Institutes of Health, and the opportunity is centered on ensuring the HIV/AIDS Clinical Trials Networks have robust, centralized laboratory leadership and capabilities to support the development and execution of laboratory elements across their research and clinical trial portfolios.

• The National Institutes of Health in the education, health, income security and social services sector is offering a public funding opportunity titled "HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121, 93.242, 93.279, 93.853, 93.855, 93.865.
• This funding opportunity was created on 2019-01-24.
• Applicants must submit their applications by 2019-08-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AI 19 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: